Advertisement
Screener

Gene Biotherapeutics, Inc. Form CORRESP: Company correspondence with SEC staff

Gene Biotherapeutics, Inc. Form CORRESP: Company correspondence with SEC staff

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2013-04-25: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
  • 2011-04-11: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
  • 2011-03-18: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
  • 2011-03-10: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
FiledFormPeriod of reportDescriptionDocument
2013-04-25CORRESPCompany correspondence with SEC stafffilename1.htm
2011-04-11CORRESPCompany correspondence with SEC stafffilename1.htm
2011-03-18CORRESPCompany correspondence with SEC stafffilename1.htm
2011-03-10CORRESPCompany correspondence with SEC stafffilename1.htm
2011-03-02CORRESPCompany correspondence with SEC stafffilename1.htm
2011-01-07CORRESPCompany correspondence with SEC stafffilename1.htm
2010-12-23CORRESPCompany correspondence with SEC stafffilename1.htm
2010-12-20CORRESPCompany correspondence with SEC stafffilename1.htm
2010-11-09CORRESPCompany correspondence with SEC stafffilename1.htm
2010-08-25CORRESPCompany correspondence with SEC stafffilename1.htm
2010-08-25CORRESPCompany correspondence with SEC stafffilename1.htm
2007-05-24CORRESPCompany correspondence with SEC stafffilename1.htm
2005-11-09CORRESPCompany correspondence with SEC stafffilename1.htm